ArticleThe FEBS journal2025
Genomic context analysis enables the discovery of an unusual NAD-dependent racemase in phosphonate catabolism.
Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Phosphonates are organic molecules containing a direct carbon-phosphorus (C-P) bond. They are chemically sturdy compounds that can, however, be degraded by environmental microorganisms. In the frame of bacterial phosphonate catabolism, we recently reported the discovery of (R)-1-hydroxy-2-aminoethylphosphonate ammonia-lyase (PbfA), a lyase acting on the natural compound (R)-2-amino-1-hydroxyethylphosphonate (R-HAEP). PbfA converts R-HAEP into phosphonoacetaldehyde (PAA), which can be subsequently processed and cleaved by further enzymes. However, PbfA is not active toward S-HAEP (the enantiomer of R-HAEP), whose metabolic fate remained unknown. We now describe the identification of a racemase, discovered through genomic context analysis, which converts S-HAEP into R-HAEP, thereby enabling degradation of S-HAEP. We propose for this enzyme the official name 2-amino-1-hydroxyethylphosphonate racemase (shorthand PbfF). To our knowledge, PbfF is the first NAD-dependent racemase ever described and is structurally unrelated to other known NAD-dependent isomerases. The enzyme uses NAD
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.